Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.580
-0.170 (-6.18%)
At close: Sep 25, 2026, 4:00 PM EDT
2.590
+0.010 (0.39%)
After-hours: Sep 25, 2026, 6:26 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $396.24 million as of September 25, 2026. Its market cap has increased by 30.76% in one year.
Market Cap
396.24M
Enterprise Value
200.10M
1-Year Change
30.76%
Ranking
Category
Stock Price
$2.58
ChartMarket Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $620.67M to $396.24M, a decrease of -36.16%. That is a compound annual growth rate of -4.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 396.24M | 98.00% |
| Dec 31, 2025 | 200.12M | 90.89% |
| Dec 31, 2024 | 104.84M | -87.33% |
| Dec 29, 2023 | 827.35M | 38.68% |
| Dec 30, 2022 | 596.59M | -66.78% |
| Dec 31, 2021 | 1.80B | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 432.29M |
| Prothena Corporation | 427.12M |
| DiaMedica Therapeutics | 422.24M |
| Atea Pharmaceuticals | 414.66M |
| ARS Pharmaceuticals | 412.71M |
| Rezolute | 411.60M |
| Prelude Therapeutics | 410.95M |
| Scribe Therapeutics | 409.11M |